For Investors - Segra International
Segra International is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally.
Segra, Cannabis Micropropagation, Cannabis Tissue Culture, Research and Development, R&D, Quality Management Systems, facilities, plant-based medicines, medicinal, Cannabis, botanical, tissue culture, specialist, Genotyping Services, Tissue Culture Production, Modular Growing Facility, Micropropagation
125
page-template,page-template-full_width,page-template-full_width-php,page,page-id-125,ajax_fade,page_not_loaded,,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

For Investors

Segra provides plant micropropagation service programs for commercial growers and nurseries.  We bring together a world-class team including experts from the fields of plant tissue culture, molecular biology, agronomy, and nursery operations, to produce high quality, clean-stock plants for the agricultural and horticultural sectors. 

Segra is an advanced stage applicant with Health Canada to become a Licensed Producer and legal distributor of medical Cannabis spp.. We are currently developing a cannabis micropropagation production facility to provide starting plant materials to the global cannabis market.

The company’s emphasis on quality, integrity, and science continues to attract and retain a team of world-class multidisciplinary science and business professionals.

For investor relations or
more information please contact:

Sam Woolf
Investor Relations
(604) 546-1369
sam.woolf@segra-intl.com